Kazunori Hirokawa
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Kazunori Hirokawa
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 43 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kazunori Hirokawa
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| QUEST DIAGNOSTICS INCORPORATED | Services to the Health Industry | Corporate Officer/Principal | |
The Robert Wood Johnson Foundation
 The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous The Robert Wood Johnson Foundation (RWJF) is an independent philanthropic organization headquartered in Princeton, New Jersey. The firm was founded in 1972 and is dedicated solely to health. RWJF funds a wide array of programs which are working to help build a national Culture of Health. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| SANOFI | Biotechnology | Director/Board Member | |
Sankyo Pharma GmbH
 Sankyo Pharma GmbH Medical DistributorsDistribution Services Part of Daiichi Sankyo Co., Ltd., Sankyo Pharma GmbH is a German pharmaceutical distribution company. The company is based in Munich, Germany. Jan van Ruymbeke has been the CEO of the company since 2012. | Medical Distributors | Chairman | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Medocity, Inc.
 Medocity, Inc. Medical/Nursing ServicesHealth Services Medocity, Inc. develops a care platform that bridges the gap between the clinic and the patient?s home. It offers a patient-centric mobile solution that combines key aspects of disease-specific care into a platform that can be used on application and Web-based devices. The firm platform also tracks key symptoms and side effects in real time; displays reports and graphic summaries to understand the patient?s health status on a daily basis. The company is headquartered in Parsippany, NJ. | Medical/Nursing Services | Director/Board Member | |
| SUMITOMO MITSUI FINANCIAL GROUP, INC. | Major Banks | President | |
| MEI PHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Keio University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Stony Brook University | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree | |
| University of Connecticut | College/University | Corporate Officer/Principal | |
| University of San Diego | College/University | Masters Business Admin | |
| University of Tokyo | College/University | Graduate Degree Graduate Degree Graduate Degree | |
National Hospital Organization
 National Hospital Organization Hospital/Nursing ManagementHealth Services National Hospital Organization is an independent administrative agency under the umbrella of Ministry of Health, Labour, and Welfare of Japan that operates medical institutions. It provides medical and healthcare services. The firm also offers medical research and development, and healthcare engineers and medical technicians training. The organization was founded on April 4, 2004 and is headquartered in Tokyo, Japan. | Hospital/Nursing Management | Director/Board Member | |
| JAPAN POST HOLDINGS CO., LTD. | Life/Health Insurance | President Director/Board Member | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
| St. Luke's International Hospital | President | ||
| Japan Hospital Association | Director/Board Member | ||
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Compliance Officer | |
| CELCUITY INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Kitasato Daiichi Sankyo Vaccine Co., Ltd.
 Kitasato Daiichi Sankyo Vaccine Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Daiichi Sankyo Co., Ltd., Kitasato Daiichi Sankyo Vaccine Co., Ltd. develops, manufactures and distributes vaccines. The company is based in Kitamoto, Japan. Kitasato Daiichi Sankyo Vaccine Co. was acquired by Daiichi Sankyo Co., Ltd. from The Kitasato Institute on November 30, 2017. | Pharmaceuticals: Major | President President | |
Taiho Oncology, Inc.
 Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Compliance Officer | |
| St. Luke's International University | College/University | President | |
| The Japan Medical Library Association | Chairman | ||
| SOLID BIOSCIENCES INC. | Biotechnology | Director/Board Member | |
Schering-Plough SAS
 Schering-Plough SAS Pharmaceuticals: MajorHealth Technology Founded in 1900, Schering-Plough SAS is a French pharmaceutical company that manufactures pharmaceutical products. Part of Merck & Co., Inc., the company is based in Puteaux, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Spotlight Therapeutics, Inc.
 Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Spotlight Therapeutics, Inc. engages in gene editing therapeutics. It focused in reprogramming tumor microenvironment. The company was founded by Alex Marson, Patrick Hsu, and Jacob Corn in 2017 and is headquartered in Hayward, CA. | Pharmaceuticals: Generic | Director/Board Member | |
Johnson & Johnson Medical SAS
 Johnson & Johnson Medical SAS Medical DistributorsDistribution Services Part of Johnson & Johnson, Johnson & Johnson Medical SAS is a French company that wholesales pharmaceutical products. The company is based in Issy-les-Moulineaux, France. The CEO of the company is Myriam Martinez Climent. | Medical Distributors | Corporate Officer/Principal | |
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Daiichi Sankyo Biotech Co. Ltd. | Chairman | ||
St. Luke's SRL Advanced Clinical Research Center, Inc.
 St. Luke's SRL Advanced Clinical Research Center, Inc. Miscellaneous Commercial ServicesCommercial Services St. Luke's SRL Advanced Clinical Research Center, Inc. engages in specimen inspection, research support for clinical examinations, surveys, research and examinations related to treatment and prevention of disease and information provision activities. The company was founded on April 3, 2017 and is headquartered in Tokyo, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | President | |
| Université Paris-Saclay | College/University | Doctorate Degree | |
| CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a company that aims to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company is based in Lake Forest, IL. The company's unrelenting commitment is to advocate boldly and care fiercely for patients and families. The company works together to confront the challenges of treating complex diseases and are advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Joseph Nolan has been the CEO of the company since 2020. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| Rutgers Robert Wood Johnson Medical School | College/University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 27 |
| Japan | 14 |
| Frankreich | 7 |
| Vereinigtes Königreich | 3 |
| Deutschland | 2 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 12 |
| Health Services | 5 |
| Finance | 4 |
| Distribution Services | 3 |
Operativ
| Director/Board Member | 79 |
| Corporate Officer/Principal | 43 |
| Independent Dir/Board Member | 18 |
| Chairman | 16 |
| President | 14 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Kazunori Hirokawa
- Unternehmensverbindungen